Aspacytarabine for the treatment of patients with AML unfit for intensive chemotherapy: a phase 2 study

Jessica K. Altman*, Tsila Zuckerman, Jamie Koprivnikar, James McCloskey, Vamsi Kota, Michael Keng, Olga Frankfurt, Yasmin Abaza, Dale L. Bixby, Ashkan Emadi, Micah Burch, Bhavana Bhatnagar, Selina M. Luger, Mary Elizabeth Percival, Ofir Wolach, Michael Craig, Chezi Ganzel, Gail Roboz, Itai Levi, Anna GourevitchLiat Flaishon, Shoshi Tessler, Chen Blumberg, Stela Gengrinovitch, Ruth Ben Yakar, Jacob M. Rowe

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Aspacytarabine for the treatment of patients with AML unfit for intensive chemotherapy: a phase 2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences